Literature DB >> 18306300

Neuroanatomical and behavioral effects of a novel version of the cholinergic immunotoxin mu p75-saporin in mice.

Pierre-Henri Moreau1, Brigitte Cosquer, Hélène Jeltsch, Jean-Christophe Cassel, Chantal Mathis.   

Abstract

The selective lesion of basal forebrain cholinergic neurons (BFCNs) is an unestimable tool to study the implication of these neurons in cognition, an interest widely motivated by their degeneration in Alzheimer's disease. Here we evaluated the histochemical and behavioral effects of a selective lesion of BFCNs in C57BL/6J mice treated intracerebroventricularly (ICV) with a novel version of the immunotoxin mu p75-saporin (0.4 mug/mouse). There was a 100% postsurgical survival rate, no abnormal loss of weight, no disruption of sensorimotor coordination, and no noncognitive bias in a water-maze test. This immunotoxin induced a loss of choline acetyltransferase-positive neurons in the medial septum (-82%) and in the nucleus basalis (-55%). Preserved parvalbumine-immunostaining suggests that the lesion was specific to BFCNs. Septo-hippocampal and basalo-cortical projections of BFCNs degenerated as suggested by massive loss of acetylcholinesterase-positive staining in the hippocampus and the cortical mantle. Moreover, anticalbindin immunostaining showed no damage to cerebellar Purkinje cells. Lesioned mice displayed increased diurnal and nocturnal locomotor activity. Their spatial learning/memory performances in a water maze and in a Barnes maze were significantly impaired: learning was substantially slowed down, although not obliterated, and memory retention was altered. These behavioral consequences are comparable, with fewer side effects, to those reported after ICV 192 IgG-saporin in rats. In conclusion, the new version of mu p75-saporin provides a safe and powerful tool for BFCN lesion in mice. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306300     DOI: 10.1002/hipo.20422

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  26 in total

1.  The role of cholinergic basal forebrain neurons in adenosine-mediated homeostatic control of sleep: lessons from 192 IgG-saporin lesions.

Authors:  A V Kalinchuk; R W McCarley; D Stenberg; T Porkka-Heiskanen; R Basheer
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

2.  Selective activation of a putative reinforcement signal conditions cued interval timing in primary visual cortex.

Authors:  Cheng-Hang Liu; Jason E Coleman; Heydar Davoudi; Kechen Zhang; Marshall G Hussain Shuler
Journal:  Curr Biol       Date:  2015-05-21       Impact factor: 10.834

3.  The role of p75NTR in cholinergic basal forebrain structure and function.

Authors:  Zoran Boskovic; Fabienne Alfonsi; Bree A Rumballe; Sachini Fonseka; Francois Windels; Elizabeth J Coulson
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

4.  Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.

Authors:  Shannon L Risacher; Brenna C McDonald; Eileen F Tallman; John D West; Martin R Farlow; Fredrick W Unverzagt; Sujuan Gao; Malaz Boustani; Paul K Crane; Ronald C Petersen; Clifford R Jack; William J Jagust; Paul S Aisen; Michael W Weiner; Andrew J Saykin
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

5.  Early behavioral changes and quantitative analysis of neuropathological features in murine prion disease: stereological analysis in the albino Swiss mice model.

Authors:  Roseane Borner; João Bento-Torres; Diego R V Souza; Danyelle B Sadala; Nonata Trevia; José Augusto Farias; Nara Lins; Aline Passos; Amanda Quintairos; José Antônio Diniz; Victor Hugh Perry; Pedro Fernando Vasconcelos; Colm Cunningham; Cristovam W Picanço-Diniz
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

6.  Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium.

Authors:  Robert H Field; Anna Gossen; Colm Cunningham
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

7.  Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Mar Pacheco-Herrero; Diana Thyssen; Maria Isabel Murillo-Carretero; Esther Berrocoso; Tara L Spires-Jones; Brian J Bacskai; Monica Garcia-Alloza
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

8.  Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation.

Authors:  Amanda C Martyn; Xavier De Jaeger; Ana C Magalhães; Rohit Kesarwani; Daniela F Gonçalves; Sanda Raulic; Monica S Guzman; Michael F Jackson; Ivan Izquierdo; John F Macdonald; Marco A M Prado; Vania F Prado
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 9.  Potential roles of cholinergic modulation in the neural coding of location and movement speed.

Authors:  Holger Dannenberg; James R Hinman; Michael E Hasselmo
Journal:  J Physiol Paris       Date:  2016-09-24

10.  Aging in the cerebellum and hippocampus and associated behaviors over the adult life span of CB6F1 mice.

Authors:  J A Kennard; K L Brown; D S Woodruff-Pak
Journal:  Neuroscience       Date:  2013-06-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.